Report cover image

Global Custom Synthetic Genes Market Outlook and Growth Opportunities 2025

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 195 Pages
SKU # APRC20280073

Description

Summary

According to APO Research, the global Custom Synthetic Genes market is projected to grow from US$ million in 2025 to US$ million by 2031, at a compound annual growth rate (CAGR) of % during the forecast period.

The North American market for Custom Synthetic Genes is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % from 2025 through 2031.

The Asia-Pacific market for Custom Synthetic Genes is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

In China, the Custom Synthetic Genes market is expected to rise from $ million to $ million by 2031, at a CAGR of I% from 2025 through 2031.

The Europe market for Custom Synthetic Genes is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Major global companies in the Custom Synthetic Genes market include Azenta Life Sciences, BBI, Bio Basic, DNA 2.0 (ATUM), Eurofins Genomics, Genescript, IDT, OriGene and SBS Genetech, etc. In 2024, the top three vendors accounted for approximately % of the market revenue.

This report presents an overview of global market for Custom Synthetic Genes, revenue and gross margin. Analyses of the global market trends, with historic market revenue for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Custom Synthetic Genes, also provides the value of main regions and countries. Of the upcoming market potential for Custom Synthetic Genes, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Custom Synthetic Genes revenue, market share and industry ranking of main companies, data from 2020 to 2025. Identification of the major stakeholders in the global Custom Synthetic Genes market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
All companies have demonstrated varying levels of sales growth and profitability over the past six years, while some companies have experienced consistent growth, others have shown fluctuations in performance. The overall trend suggests a positive outlook for the global Custom Synthetic Genes company landscape, with companies adapting to market dynamics and maintaining profitability amidst changing conditions.
Custom Synthetic Genes Segment by Company

Azenta Life Sciences
BBI
Bio Basic
DNA 2.0 (ATUM)
Eurofins Genomics
Genescript
IDT
OriGene
SBS Genetech
Thermo Scientific
Twist Bioscience
Custom Synthetic Genes Segment by Type

Above 5000 bp
3001- 5000 bp
1001 - 3000 bp
Below 1000 bp
Custom Synthetic Genes Segment by Application

Commercial
Academic Research
Custom Synthetic Genes Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global Custom Synthetic Genes status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the Custom Synthetic Genes key companies, revenue, market share, and recent developments.
3. To split the Custom Synthetic Genes breakdown data by regions, type, companies, and application.
4. To analyze the global and key regions Custom Synthetic Genes market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Custom Synthetic Genes significant trends, drivers, influence factors in global and regions.
6. To analyze Custom Synthetic Genes competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Custom Synthetic Genes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Custom Synthetic Genes and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Custom Synthetic Genes.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Custom Synthetic Genes industry.
Chapter 3: Detailed analysis of Custom Synthetic Genes company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales value of Custom Synthetic Genes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.
Chapter 7: Sales value of Custom Synthetic Genes in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 9: Concluding Insights.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

195 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Custom Synthetic Genes Market Size, 2020 VS 2024 VS 2031
1.3 Global Custom Synthetic Genes Market Size (2020-2031)
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Custom Synthetic Genes Market Dynamics
2.1 Custom Synthetic Genes Industry Trends
2.2 Custom Synthetic Genes Industry Drivers
2.3 Custom Synthetic Genes Industry Opportunities and Challenges
2.4 Custom Synthetic Genes Industry Restraints
3 Custom Synthetic Genes Market by Company
3.1 Global Custom Synthetic Genes Company Revenue Ranking in 2024
3.2 Global Custom Synthetic Genes Revenue by Company (2020-2025)
3.3 Global Custom Synthetic Genes Company Ranking (2023-2025)
3.4 Global Custom Synthetic Genes Company Manufacturing Base and Headquarters
3.5 Global Custom Synthetic Genes Company Product Type and Application
3.6 Global Custom Synthetic Genes Company Establishment Date
3.7 Market Competitive Analysis
3.7.1 Global Custom Synthetic Genes Market Concentration Ratio (CR5 and HHI)
3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2024
3.7.3 2024 Custom Synthetic Genes Tier 1, Tier 2, and Tier 3 Companies
3.8 Mergers and Acquisitions Expansion
4 Custom Synthetic Genes Market by Type
4.1 Custom Synthetic Genes Type Introduction
4.1.1 Above 5000 bp
4.1.2 3001- 5000 bp
4.1.3 1001 - 3000 bp
4.1.4 Below 1000 bp
4.2 Global Custom Synthetic Genes Sales Value by Type
4.2.1 Global Custom Synthetic Genes Sales Value by Type (2020 VS 2024 VS 2031)
4.2.2 Global Custom Synthetic Genes Sales Value by Type (2020-2031)
4.2.3 Global Custom Synthetic Genes Sales Value Share by Type (2020-2031)
5 Custom Synthetic Genes Market by Application
5.1 Custom Synthetic Genes Application Introduction
5.1.1 Commercial
5.1.2 Academic Research
5.2 Global Custom Synthetic Genes Sales Value by Application
5.2.1 Global Custom Synthetic Genes Sales Value by Application (2020 VS 2024 VS 2031)
5.2.2 Global Custom Synthetic Genes Sales Value by Application (2020-2031)
5.2.3 Global Custom Synthetic Genes Sales Value Share by Application (2020-2031)
6 Custom Synthetic Genes Regional Value Analysis
6.1 Global Custom Synthetic Genes Sales Value by Region: 2020 VS 2024 VS 2031
6.2 Global Custom Synthetic Genes Sales Value by Region (2020-2031)
6.2.1 Global Custom Synthetic Genes Sales Value by Region: 2020-2025
6.2.2 Global Custom Synthetic Genes Sales Value by Region (2026-2031)
6.3 North America
6.3.1 North America Custom Synthetic Genes Sales Value (2020-2031)
6.3.2 North America Custom Synthetic Genes Sales Value Share by Country, 2024 VS 2031
6.4 Europe
6.4.1 Europe Custom Synthetic Genes Sales Value (2020-2031)
6.4.2 Europe Custom Synthetic Genes Sales Value Share by Country, 2024 VS 2031
6.5 Asia-Pacific
6.5.1 Asia-Pacific Custom Synthetic Genes Sales Value (2020-2031)
6.5.2 Asia-Pacific Custom Synthetic Genes Sales Value Share by Country, 2024 VS 2031
6.6 South America
6.6.1 South America Custom Synthetic Genes Sales Value (2020-2031)
6.6.2 South America Custom Synthetic Genes Sales Value Share by Country, 2024 VS 2031
6.7 Middle East & Africa
6.7.1 Middle East & Africa Custom Synthetic Genes Sales Value (2020-2031)
6.7.2 Middle East & Africa Custom Synthetic Genes Sales Value Share by Country, 2024 VS 2031
7 Custom Synthetic Genes Country-level Value Analysis
7.1 Global Custom Synthetic Genes Sales Value by Country: 2020 VS 2024 VS 2031
7.2 Global Custom Synthetic Genes Sales Value by Country (2020-2031)
7.2.1 Global Custom Synthetic Genes Sales Value by Country (2020-2025)
7.2.2 Global Custom Synthetic Genes Sales Value by Country (2026-2031)
7.3 USA
7.3.1 USA Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.3.2 USA Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.3.3 USA Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.4 Canada
7.4.1 Canada Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.4.2 Canada Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.4.3 Canada Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.5 Mexico
7.5.1 Mexico Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.5.2 Mexico Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.5.3 Mexico Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.6 Germany
7.6.1 Germany Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.6.2 Germany Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.6.3 Germany Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.7 France
7.7.1 France Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.7.2 France Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.7.3 France Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.8 U.K.
7.8.1 U.K. Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.8.2 U.K. Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.8.3 U.K. Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.9 Italy
7.9.1 Italy Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.9.2 Italy Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.9.3 Italy Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.10 Spain
7.10.1 Spain Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.10.2 Spain Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.10.3 Spain Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.11 Russia
7.11.1 Russia Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.11.2 Russia Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.11.3 Russia Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.12 Netherlands
7.12.1 Netherlands Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.12.2 Netherlands Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.12.3 Netherlands Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.13 Nordic Countries
7.13.1 Nordic Countries Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.13.2 Nordic Countries Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.13.3 Nordic Countries Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.14 China
7.14.1 China Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.14.2 China Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.14.3 China Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.15 Japan
7.15.1 Japan Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.15.2 Japan Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.15.3 Japan Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.16 South Korea
7.16.1 South Korea Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.16.2 South Korea Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.16.3 South Korea Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.17 India
7.17.1 India Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.17.2 India Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.17.3 India Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.18 Australia
7.18.1 Australia Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.18.2 Australia Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.18.3 Australia Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.19 Southeast Asia
7.19.1 Southeast Asia Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.19.2 Southeast Asia Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.19.3 Southeast Asia Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.20 Brazil
7.20.1 Brazil Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.20.2 Brazil Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.20.3 Brazil Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.21 Argentina
7.21.1 Argentina Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.21.2 Argentina Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.21.3 Argentina Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.22 Chile
7.22.1 Chile Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.22.2 Chile Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.22.3 Chile Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.23 Colombia
7.23.1 Colombia Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.23.2 Colombia Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.23.3 Colombia Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.24 Peru
7.24.1 Peru Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.24.2 Peru Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.24.3 Peru Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.25 Saudi Arabia
7.25.1 Saudi Arabia Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.25.2 Saudi Arabia Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.25.3 Saudi Arabia Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.26 Israel
7.26.1 Israel Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.26.2 Israel Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.26.3 Israel Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.27 UAE
7.27.1 UAE Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.27.2 UAE Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.27.3 UAE Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.28 Turkey
7.28.1 Turkey Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.28.2 Turkey Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.28.3 Turkey Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.29 Iran
7.29.1 Iran Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.29.2 Iran Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.29.3 Iran Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
7.30 Egypt
7.30.1 Egypt Custom Synthetic Genes Sales Value Growth Rate (2020-2031)
7.30.2 Egypt Custom Synthetic Genes Sales Value Share by Type, 2024 VS 2031
7.30.3 Egypt Custom Synthetic Genes Sales Value Share by Application, 2024 VS 2031
8 Company Profiles
8.1 Azenta Life Sciences
8.1.1 Azenta Life Sciences Comapny Information
8.1.2 Azenta Life Sciences Business Overview
8.1.3 Azenta Life Sciences Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
8.1.4 Azenta Life Sciences Custom Synthetic Genes Product Portfolio
8.1.5 Azenta Life Sciences Recent Developments
8.2 BBI
8.2.1 BBI Comapny Information
8.2.2 BBI Business Overview
8.2.3 BBI Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
8.2.4 BBI Custom Synthetic Genes Product Portfolio
8.2.5 BBI Recent Developments
8.3 Bio Basic
8.3.1 Bio Basic Comapny Information
8.3.2 Bio Basic Business Overview
8.3.3 Bio Basic Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
8.3.4 Bio Basic Custom Synthetic Genes Product Portfolio
8.3.5 Bio Basic Recent Developments
8.4 DNA 2.0 (ATUM)
8.4.1 DNA 2.0 (ATUM) Comapny Information
8.4.2 DNA 2.0 (ATUM) Business Overview
8.4.3 DNA 2.0 (ATUM) Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
8.4.4 DNA 2.0 (ATUM) Custom Synthetic Genes Product Portfolio
8.4.5 DNA 2.0 (ATUM) Recent Developments
8.5 Eurofins Genomics
8.5.1 Eurofins Genomics Comapny Information
8.5.2 Eurofins Genomics Business Overview
8.5.3 Eurofins Genomics Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
8.5.4 Eurofins Genomics Custom Synthetic Genes Product Portfolio
8.5.5 Eurofins Genomics Recent Developments
8.6 Genescript
8.6.1 Genescript Comapny Information
8.6.2 Genescript Business Overview
8.6.3 Genescript Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
8.6.4 Genescript Custom Synthetic Genes Product Portfolio
8.6.5 Genescript Recent Developments
8.7 IDT
8.7.1 IDT Comapny Information
8.7.2 IDT Business Overview
8.7.3 IDT Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
8.7.4 IDT Custom Synthetic Genes Product Portfolio
8.7.5 IDT Recent Developments
8.8 OriGene
8.8.1 OriGene Comapny Information
8.8.2 OriGene Business Overview
8.8.3 OriGene Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
8.8.4 OriGene Custom Synthetic Genes Product Portfolio
8.8.5 OriGene Recent Developments
8.9 SBS Genetech
8.9.1 SBS Genetech Comapny Information
8.9.2 SBS Genetech Business Overview
8.9.3 SBS Genetech Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
8.9.4 SBS Genetech Custom Synthetic Genes Product Portfolio
8.9.5 SBS Genetech Recent Developments
8.10 Thermo Scientific
8.10.1 Thermo Scientific Comapny Information
8.10.2 Thermo Scientific Business Overview
8.10.3 Thermo Scientific Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
8.10.4 Thermo Scientific Custom Synthetic Genes Product Portfolio
8.10.5 Thermo Scientific Recent Developments
8.11 Twist Bioscience
8.11.1 Twist Bioscience Comapny Information
8.11.2 Twist Bioscience Business Overview
8.11.3 Twist Bioscience Custom Synthetic Genes Revenue and Gross Margin (2020-2025)
8.11.4 Twist Bioscience Custom Synthetic Genes Product Portfolio
8.11.5 Twist Bioscience Recent Developments
9 Concluding Insights
10 Appendix
10.1 Reasons for Doing This Study
10.2 Research Methodology
10.3 Research Process
10.4 Authors List of This Report
10.5 Data Source
10.5.1 Secondary Sources
10.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.